|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 413/14 | |
| A61K 31/422 | |||
| A61K 31/4439 | |||
| A61P 35/00 | |||
| A61P 37/00 | |||
| A61P 11/00 | |||
| A61P 31/12 |
| (11) | Number of the document | 3260453 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17182412.1 |
| Date of filing the European patent application | 2010-04-28 | |
| (97) | Date of publication of the European application | 2017-12-27 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-31 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 174033 P | 2009-04-30 | US |
| (72) |
HAMBLIN, Julie Nicole, GB
JONES, Paul Spencer, GB
KEELING, Suzanne Elaine, GB
LE, Joelle, GB
MITCHELL, Charlotte Jane, GB
PARR, Nigel James, GB
|
| (73) |
Glaxo Group Limited,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
| (54) | OXAZOLE SUBSTITUTED INDAZOLES AS PI3-KINASE INHIBITORS |
| OXAZOLE SUBSTITUTED INDAZOLES AS PI3-KINASE INHIBITORS |